Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Tetra Bio-Pharma Inc. (C:TBP)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
See Regulatory Filings on SEDAR
Company Contact
Address: 2742 St. Joseph Blvd Unit 200
Tel: 1-514-3608040
IR: See website
Key People
Guy Chamberland
Chief Executive Officer, Chief Scientific Officer
Ryan Brown
Vice President - Business Development
Sabino Di Paola
Chief Financial Officer
Richard Giguere
Executive Vice President - Commercial Operations
Steve Neron
Senior Vice President - Marketing and Medical Affairs
Melanie Kelly
Chief Scientific Officer
Robert Bechard
Vice President, Finance and Business Development
Denis Courchesne
Vice President of Sales
Edward Miller
Vice President of Investor Relations & Corporate Communications
Aurelia De Pauw
Vice President - Clinical Programs and Medical Affairs
Business Overview
Tetra Bio Pharma Inc is a Canada-based company engaged in the development of bio pharmaceuticals and natural health products containing cannabis and other medicinal plant based elements. The Company is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. The Company objective is to bring smokable, natural medical marijuana to the market along with a number of other products targeting chronic pain, insomnia, post-traumatic stress disorder (PTSD), anxiety, among others. The Company operates through three divisions: PhytoPain Pharma Inc, Agro Tek Health and Grow Pros Cannabis Ventures Inc.
Financial Overview
For the nine months ended 31 August 2019, Tetra Bio Pharma Inc revenues was not reported. Net loss before extraordinary items increased from C$3M to C$10.7M. Higher net loss reflects Gain on disposal of GrowPros MMP decrease from C$4.2M (income) to C$0K, Research and development increase of 45% to C$5.1M (expense), Payroll and benefits increase from C$729K to C$2.2M (expense).
Reporting Currency: Canadian Dollars
Enterprise value: $105.61M as of Aug 31, 2019
Annual revenue (TTM): $0.11M as of Aug 31, 2019
EBITDA (TTM): -$14.35M as of Aug 31, 2019
Net annual income (TTM): -$15.27M as of Aug 31, 2019
Free cash flow (TTM): -$15.20M as of Aug 31, 2019
Net Debt Last Fiscal Year: N/A
Shares outstanding: 212,841,411 as of Dec 30, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization